GWM
TTOO

Geneos Wealth Management’s T2 Biosystems, Inc TTOO Stock Holding History

Geneos Wealth Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11
Closed -$6K – 2112
2022
Q3 		$6K Sell
11
-5
-31% -$3.29K ﹤0.01% 1669
2022
Q2 		$13K Hold
16
– – ﹤0.01% 1863
2022
Q1 		$42K Hold
16
– – ﹤0.01% 1463
2021
Q4 		$41K Hold
16
– – ﹤0.01% 1566
2021
Q3 		$75K Buy
16
+3
+23% +$15.1K ﹤0.01% 1292
2021
Q2 		$75K Buy
+13
New +$83.9K ﹤0.01% 1291
2020
Q4 		– Sell
-1
Closed -$5K – 3027
2020
Q3 		$5K Buy
+1
New +$7.41K ﹤0.01% 2213
2017
Q1 		– Hold
0
– -$10K – 2157
2016
Q4 		– Hold
0
– – – 1445

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Geneos Wealth Management's TTOO Position: Q4 2022 in Review

Geneos Wealth Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 11 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in TTOO in Q3 2020 and held it in 7 quarters. The position peaked at $75K in Q3 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Geneos Wealth Management reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 11 T2 Biosystems, Inc shares in Q4 2022, an estimated $6K.
  • Geneos Wealth Management first reported a position in T2 Biosystems, Inc in Q3 2020 and held it in 7 quarters.
  • Geneos Wealth Management's T2 Biosystems, Inc position peaked at $75K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.